MiR-323a-3p suppressed the glycolysis of osteosarcoma via targeting LDHA

被引:36
|
作者
Chen, Hanwen [1 ]
Gao, Shuming [1 ]
Cheng, Cai [1 ]
机构
[1] Cangzhou Cent Hosp, Dept Orthoped 1, Cangzhou 061000, Hebei, Peoples R China
关键词
MiR-323a-3p; Osteosarcoma; LDHA; Glycolysis; CELL-PROLIFERATION; AEROBIC GLYCOLYSIS; MIRNA EXPRESSION; GASTRIC-CANCER; INVASION; INHIBITION; METABOLISM; MIGRATION;
D O I
10.1007/s13577-018-0215-0
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Accumulating evidence has demonstrated that there is critical involvement of miRNAs in the initiation and progression of cancers. Here, we showed that miR-323a-3p was significantly down-regulated in osteosarcoma (OS) tissues and cell lines. Overexpression of miR-323a-3p decreased the cell viability, colon formation and induced the apoptosis of OS cells. Using bioinformatics analysis, lactate dehydrogenase A (LDHA) was predicted as one of the down-steam targets of miR-323a-3p. Highly expressed miR-323a-3p significantly decreased both the mRNA and protein levels of LDHA. Inverse correlation between the expression of LDHA and miR-323a-3p was observed in OS tissues. Consistent with the function of LDHA in glycolysis of cancer cells, overexpression of miR-323a-3p attenuated the lactate production of OS cells. These results demonstrated that miR-323a-3p suppressed the growth of OS cells via targeting LDHA and inhibited the glycolysis of OS. This study provides insight into the molecular mechanism of miR-323a-3p in regulating OS.
引用
收藏
页码:300 / 309
页数:10
相关论文
共 50 条
  • [11] LncRNA DANCR promotes the development of osteosarcoma via targeting miR-758-3p
    Wu, Tao
    Zhao, Jinlong
    Ge, Lihao
    Peng, Ruijian
    Nie, Dejun
    Zhang, Jing
    Jiao, Haibin
    Zhang, Bo
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 125 : 111 - 112
  • [12] MiR-361-3p promotes tumorigenesis of osteosarcoma cells via targeting ARID3A
    Zhou, Daguo
    Ji, Guangrong
    Wei, Guojun
    Li, Zongguang
    Yu, Naichun
    Wang, Yanling
    Lin, Binhui
    Zhang, Linlin
    Yin, Yue
    TISSUE & CELL, 2022, 76
  • [13] miR-383 inhibits ovarian cancer cell proliferation, invasion and aerobic glycolysis by targeting LDHA
    Han, R. L.
    Wang, F. P.
    Zhang, P. A.
    Zhou, X. Y.
    Li, Y.
    NEOPLASMA, 2017, 64 (02) : 244 - +
  • [14] Chidamide suppresses the glycolysis of triple negative breast cancer cells partially by targeting the miR-33a-5p-LDHA axis
    Bai, Xiangdong
    Jiang, Hongchuan
    Han, Guohui
    He, Qiang
    MOLECULAR MEDICINE REPORTS, 2019, 20 (02) : 1857 - 1865
  • [15] Potential Regulatory Effects of miR-182-3p in Osteosarcoma via Targeting EBF2
    Chen, Gaoyang
    Yu, Wenqing
    Li, Zhaoyan
    Wang, Qingyu
    Yang, Qiwei
    Du, Zhenwu
    Zhang, Guizhen
    Song, Yang
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [16] miR-16-5p Suppresses Progression and Invasion of Osteosarcoma via Targeting at Smad3
    Gu, Zhijian
    Li, Zhikun
    Xu, Ruijun
    Zhu, Xiaodong
    Hu, Ruixi
    Xue, Yonghua
    Xu, Wei
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [17] miR-96-5p is the tumor suppressor in osteosarcoma via targeting SYK
    Wang, Taiping
    Xu, Yong
    Liu, Xin
    Zeng, Yong
    Liu, Lei
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 572 : 49 - 56
  • [18] MET/SMAD3/SNAIL circuit mediated by miR-323a-3p is involved in regulating epithelial–mesenchymal transition progression in bladder cancer
    Jiangfeng Li
    Xin Xu
    Shuai Meng
    Zhen Liang
    Xiao Wang
    Mingjie Xu
    Song Wang
    Shiqi Li
    Yi Zhu
    Bo Xie
    Yiwei Lin
    Xiangyi Zheng
    Ben Liu
    Liping Xie
    Cell Death & Disease, 2017, 8 : e3010 - e3010
  • [19] MiR-34a suppresses osteoblast differentiation through glycolysis inhibition by targeting lactate dehydrogenase-A (LDHA)
    Hong, Mu
    Zhang, Xiao-Bin
    Xiang, Fei
    Fei, Xu
    Ouyang, Xue-Lian
    Peng, Xiao-Chun
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2020, 56 (06) : 480 - 487
  • [20] MiR-323a-3p acts as a tumor suppressor by suppressing FMR1 and predicts better esophageal squamous cell carcinoma outcome
    Yu Men
    Yirui Zhai
    Lihong Wu
    Lipin Liu
    Wenjue Zhang
    Wei Jiang
    Nan Bi
    Yongmei Song
    Zhouguang Hui
    Luhua Wang
    Cancer Cell International, 22